“How Are Digital Health Companies Proving Their Worth During the COVID-19 Crisis?”

Digital startup guru Jessica Federer has called on pharma to see the COVID-19 crisis as an opportunity to become “better, faster, more agile” by embracing digital health innovations.

In her address at the ‘eyeforpharma’ Barcelona virtual conference, digital startup guru Jessica Federer said that the COVID-19 pandemic presents an opportunity for digital health companies to prove their worth.

They also have an opportunity to elevate the status of digital health solutions as the standard of care when dealing with infectious diseases.

She also said that companies working in areas such as electronic health record sharing, AI/natural language processing of literature related to COVID-19 and telecare, have a key role in the fight against the coronavirus pandemic.

Given the quarantine situation, more people are willing to try digital solutions for their non-urgent medical conditions.

If these people have positive experiences with a healthcare app there is a chance they might stick to it rather than go out and wait in line at the doctor’s office.

But digital health companies must first demonstrate their core capabilities and what they can do better than anyone else, especially in times of crisis.


    1. The COVID-19 crisis presents an opportunity for digital health solutions to become the standard of care when it comes to infectious diseases.
    2. More people are now willing to try digital health solutions because of the quarantine measures and digital health companies should make sure to give these patients positive experiences.
    3. Having a positive experience can make people stick to digital health solutions.

“This is the time they get to prove what they can do if given the opportunity, and if they take advantage of that opportunity they have the chance to change the status quo – to make digital health solutions the standard of care when it comes to infectious disease, at the very least,” says digital startup guru Jessica Federer.

Article source: https://bit.ly/3aRjJLz

#Healthcare, #DigitalHealth, #COVID-19, #Pharma

P.S. Staying up-to-date with what’s new in Clinical Trials? Get the latest articles summarized and delivered free to your e-mail inbox. Click here to learn more.

Latest news

ACTide by Nubilaria against COVID-19

DECEIVER trial for COVID-19 related ARDS intensive care

Read more
Nubilaria for EUROLogin2020


Read more
Nubilaria ACTide @ SCOPE Virtual 2021

SCOPE – Summit for Clinical Ops Executives

Read more
Nubilaria Christmas wishes 2020

Merry Christmas and Happy new Year

Read more

Want more information about our solutions?
Contact us today.

I've read and accept theTerms and Conditions and the Privacy Policy
   I would like to receive information about products and services via traditional mail, telephone, email and automated communication systems